Market Overview

OvaCue Fertility Monitor vs. Transvaginal Ultrasound: Case Study Demonstrates Accuracy of the OvaCue

Share:

Fairhaven Health's OvaCue Fertility Monitor is an electronic device designed for at-home use, and intended to be used by trying to conceive women to identify their most fertile days in each menstrual cycle. The OvaCue offers the most advanced technology available for ovulation prediction and has been shown to over 98% accurate in NIH-funded studies. The results of a recent case study comparing the results of the OvaCue with the "gold standard" in ovulation prediction, the transvaginal ultrasound, verify the accuracy of the OvaCue for accurately pinpointing the most fertile days in a woman's cycle.

Bellingham, Washington (PRWEB) October 30, 2012

When you're trying to conceive, knowing when you ovulate each month – your peak fertile time – is particularly helpful information. Transvaginal ultrasound is regarded as the most accurate means of determining this; however, visiting your doctor for a daily transvaginal ultrasound is neither practical nor affordable. So how do home fertility monitoring methods stack up against the ‘'gold standard” in terms of ability to identify peak fertility and confirm when ovulation has occurred?

The OvaCue Fertility Monitor is one of the most advanced fertility monitors available, measuring changes in electrolyte levels in both saliva and cervical mucus throughout a woman's monthly cycle to predict ovulation up to seven days in advance. The OvaCue Monitor has been shown to predict ovulation with greater than 98% accuracy in studies conducted by the National Institute of Health (NIH).

In attempt to give these statistics some real world relevance, Fairhaven Health, the manufacturer of the OvaCue Fertility Monitor, convinced its own Director of Social Media, who monitors her cycle daily with the OvaCue, to receive regular transvaginal ultrasounds throughout her monthly cycle, and then compare these results to her daily OvaCue readings.

Through this process, it was discovered that the OvaCue monitor results closely paralleled those of the transvaginal ultrasound in terms of identifying optimal fertile days in which conception would be more likely to occur. Further, both the OvaCue fertility monitor and the transvaginal ultrasound identified the same date for ovulation. Complete results of this comparison can be viewed online at the OvaCue website.

“Seeing my complete ovulatory process via ultrasound was a great experience,” she said. “While I help interpret OvaCue readings every day for our customers and am confident in its accuracy, it was nice to see it validated in this fashion through comparison with my own ultrasound results.”

About Fairhaven Health

Fairhaven Health manufactures safe, doctor-designed products to promote natural fertility, pregnancy, and nursing health. They provide ovulation prediction tools, fertility supplements, prenatal vitamins and breastfeeding support with all U.S. manufacturing governed by strict Good Manufacturing Practice Regulations overseen by the Food and Drug Administration. Distribution partners include hospitals, clinics, pharmacies, specialty retail stores and online retailers such as CVS.com, drugstore.com and walgreens.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebfairhavenhealth/ovacue-vs-ultrasound/prweb10071719.htm

View Comments and Join the Discussion!